Adenovirus vectors for gene expression. 1991

M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
Wyeth-Ayerst Research, Philadelphia, Pennsylvania.

Adenoviruses possess a combination of features that make them highly suitable as vectors for expression of heterologous genes. Non-conditional and non-defective adeno-vectors have been constructed to obtain high level expression of a number of foreign genes and some of them have been shown in animal models to exhibit excellent promise as vaccine candidates.

UI MeSH Term Description Entries
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic
D015316 Genetic Therapy Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions. Gene Therapy,Somatic Gene Therapy,DNA Therapy,Gene Therapy, Somatic,Genetic Therapy, Gametic,Genetic Therapy, Somatic,Therapy, DNA,Therapy, Gene,Therapy, Somatic Gene,Gametic Genetic Therapies,Gametic Genetic Therapy,Genetic Therapies,Genetic Therapies, Gametic,Genetic Therapies, Somatic,Somatic Genetic Therapies,Somatic Genetic Therapy,Therapies, Gametic Genetic,Therapies, Genetic,Therapies, Somatic Genetic,Therapy, Gametic Genetic,Therapy, Genetic,Therapy, Somatic Genetic
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
July 1995, Annals of the New York Academy of Sciences,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
December 2003, Uirusu,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
October 1999, Current opinion in biotechnology,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
January 2000, Advances in virus research,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
June 1993, Current opinion in genetics & development,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
January 2008, Contributions to nephrology,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
January 2000, Journal of virology,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
December 1995, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
January 1995, Current topics in microbiology and immunology,
M V Chengalvala, and M D Lubeck, and B J Selling, and R J Natuk, and K H Hsu, and B B Mason, and P K Chanda, and R A Bhat, and B M Bhat, and S Mizutani
March 1994, Cancer gene therapy,
Copied contents to your clipboard!